Karyopharm Therapeutics Inc (KPTI)

12:45 PM

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript - Yahoo Finance

12:45 PM

08:51 AM

Karyopharm Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

08:51 AM

08:40 AM

Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

08:40 AM

08:22 AM

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings: EPS Loss of - GuruFocus.com

08:22 AM

07:48 AM

Karyopharm Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

07:48 AM

07:30 AM

Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress - PR Newswire

07:30 AM

02:18 AM

Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year - Investing.com UK

02:18 AM

Nov 04, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com

Nov 04, 2024

Nov 02, 2024

KPTIKaryopharm Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024

Nov 02, 2024

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - MSN

Nov 02, 2024

Nov 01, 2024

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Nov 01, 2024

Nov 01, 2024

Karyopharm Therapeutics (KPTI) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 01, 2024

Nov 01, 2024

Karyopharm Therapeutics' (KPTI) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 01, 2024

Nov 01, 2024

Karyopharm updates SENTRY trial endpoints, eyes 2025 data - Investing.com India

Nov 01, 2024

Oct 31, 2024

Karyopharm updates SENTRY trial endpoints, eyes 2025 data By Investing.com - Investing.com Canada

Oct 31, 2024

Oct 31, 2024

Karyopharm gains after changes to late-stage trial - MSN

Oct 31, 2024

Oct 31, 2024

Karyopharm stock gains as late-stage trial changes (KPTI:NASDAQ) - Seeking Alpha

Oct 31, 2024

Oct 31, 2024

Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024 - StockTitan

Oct 31, 2024

Oct 31, 2024

Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis - StockTitan

Oct 31, 2024

Oct 30, 2024

Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024 - Investor Relations | Karyopharm Therapeutics

Oct 30, 2024

Oct 30, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Share Price Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat

Oct 30, 2024

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Karyopharm Therapeutics Shares - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Karyoph - GuruFocus.com

Oct 25, 2024

Oct 22, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Shares Cross Above 50-Day Moving AverageShould You Sell? - MarketBeat

Oct 22, 2024

Oct 14, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Holdings Lifted by AQR Capital Management LLC - MarketBeat

Oct 14, 2024

Oct 12, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 12, 2024

Oct 11, 2024

Karyopharm Therapeutics Inc [KPTI] Records 200-Day SMA of $1.0212 - Knox Daily

Oct 11, 2024

Oct 10, 2024

Ratios in Focus: Analyzing Karyopharm Therapeutics Inc (KPTI)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 10, 2024

Oct 08, 2024

KPTI’s latest rating updates from top analysts. - Knox Daily

Oct 08, 2024

Oct 08, 2024

Karyopharm Therapeutics Inc (KPTI) is looking forward to a strong quarter - SETE News

Oct 08, 2024

Oct 07, 2024

Karyopharm Therapeutics Inc (KPTI) stock analysis: A simple moving average approach - US Post News

Oct 07, 2024

Oct 05, 2024

Cubist Systematic Strategies LLC Buys New Shares in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World

Oct 05, 2024

Oct 05, 2024

Marshall Wace LLP Decreases Position in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World

Oct 05, 2024

Oct 05, 2024

Cubist Systematic Strategies LLC Takes Position in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat

Oct 05, 2024

Oct 04, 2024

Karyopharm Therapeutics Inc [NASDAQ: KPTI] Sees Decrease in Stock Value - Knox Daily

Oct 04, 2024

Oct 02, 2024

Was Karyopharm Therapeutics Inc (KPTI)’s session last reading good? - US Post News

Oct 02, 2024

Oct 01, 2024

Monitoring Karyopharm Therapeutics Inc (KPTI) after recent insider movements - Knox Daily

Oct 01, 2024

Oct 01, 2024

Analyzing the Impact of Earnings Reports on Karyopharm Therapeutics Inc Inc. (KPTI) Price Performance - The InvestChronicle

Oct 01, 2024

Oct 01, 2024

Why Investors Shouldn't Be Surprised By Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) Low P/S - Simply Wall St

Oct 01, 2024

Sep 30, 2024

Financial Snapshot: Analyzing Karyopharm Therapeutics Inc (KPTI)’s Key Ratio Metrics - The Dwinnex

Sep 30, 2024

Sep 30, 2024

A new trading data show Karyopharm Therapeutics Inc (KPTI) is showing positive returns. - SETE News

Sep 30, 2024

Sep 30, 2024

Karyopharm Therapeutics' SWOT analysis: pipeline potential drives stock outlook - Investing.com India

Sep 30, 2024

Sep 30, 2024

Karyopharm Therapeutics' SWOT analysis: pipeline potential drives stock outlook By Investing.com - Investing.com UK

Sep 30, 2024

Sep 27, 2024

SVP, General Counsel&Secretary Mano Michael sold 3,971 shares of Karyopharm Therapeutics Inc [KPTI] - Knox Daily

Sep 27, 2024

Sep 26, 2024

Karyopharm Therapeutics Inc (KPTI) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 26, 2024

Sep 26, 2024

The Globe and Mail - The Globe and Mail

Sep 26, 2024

Sep 25, 2024

A stock that deserves closer examination: Karyopharm Therapeutics Inc (KPTI) - US Post News

Sep 25, 2024

Sep 24, 2024

Metric Deep Dive: Understanding Karyopharm Therapeutics Inc (KPTI) Through its Ratios - The Dwinnex

Sep 24, 2024

Sep 23, 2024

KJTS Group shares climb to near six-week high after contract win - The Edge Malaysia

Sep 23, 2024

Sep 23, 2024

Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements - Barchart

Sep 23, 2024

Sep 23, 2024

KEC International Shares Surge 3% on Securing Orders Worth Rs 1,003 Crore - EquityPandit

Sep 23, 2024

Sep 23, 2024

KEC International Boosts Market Presence with Rs 1,003 Crore New Contracts - PUNE.NEWS

Sep 23, 2024

Sep 23, 2024

KEC International surges 3% after bagging orders worth Rs 1,003 cr; details - Business Standard

Sep 23, 2024

Sep 23, 2024

India's KEC International rises on 10.03 bln rupee order wins - XM

Sep 23, 2024

Sep 22, 2024

KEC International shares surge 4% on new orders worth Rs 1,003 crore - Moneycontrol

Sep 22, 2024

Sep 21, 2024

Acadian Asset Management LLC Invests $167,000 in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World

Sep 21, 2024

Sep 20, 2024

KEC International down 5% as CARE Ratings downgrades co's bank facilities - Business Standard

Sep 20, 2024

Sep 20, 2024

KEC International shares drop 4% after credit rating downgrade by CARE - Business Upturn

Sep 20, 2024

Sep 19, 2024

5:1 Stock Split Announced by This Multibagger Smallcap Company- Stock Hits 52-Week High Today, Gains Over 1,000 Per cent Returns in Just 1 Year! - Dalal Street Investment Journal

Sep 19, 2024

Sep 19, 2024

KHPT unveils ACE Market IPO prospectus to raise up to RM29 mil - The Edge Malaysia

Sep 19, 2024

Sep 18, 2024

Karyopharm faces Nasdaq delisting over share price woes By Investing.com - Investing.com Australia

Sep 18, 2024

Sep 17, 2024

Karyopharm faces Nasdaq delisting over share price woes - Investing.com India

Sep 17, 2024